Cat. #154176
Anti-FANCD2 [R3687]
Cat. #: 154176
Sub-type: Primary antibody
Unit size: 100 ug
Availability: 10-12 weeks
Target: Fanconi anemia complementation group D2
Class: Polyclonal
Application: IP ; WB
Reactivity: Human
Host: Rabbit
£300.00
This fee is applicable only for non-profit organisations. If you are a for-profit organisation or a researcher working on commercially-sponsored academic research, you will need to contact our licensing team for a commercial use license.
Contributor
Inventor: Maureen Hoatlin
Institute: Oregon Health & Science University
Tool Details
*FOR RESEARCH USE ONLY (for other uses, please contact the licensing team)
- Name: Anti-FANCD2 [R3687]
- Alternate name: FANCD2
- Research fields: Genetics
- Tool sub type: Primary antibody
- Class: Polyclonal
- Conjugation: Unconjugated
- Reactivity: Human
- Host: Rabbit
- Application: IP ; WB
- Immunogen: hFANCD2 amino acids 1-292
Target Details
- Target: Fanconi anemia complementation group D2
Applications
- Application: IP ; WB
Handling
- Format: Liquid
- Concentration: 0.9-1.1 mg/ml
- Unit size: 100 ug
- Storage conditions: -15° C to -25° C
- Shipping conditions: Shipping at 4° C
References
- Hlzel et al. 2003. J Pathol. 201(2):198-203. PMID: 14517836.
- Meetei et al. 2003. Nat Genet. 35(2):165-70. PMID: 12973351.
- FANCD2 protein is expressed in proliferating cells of human tissues that are cancer-prone in Fanconi anaemia.
- A novel ubiquitin ligase is deficient in Fanconi anemia.
